Delivery Order SPE2DB20D2104-SPE2DB24FR17N
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $7,384.26 to AmerisourceBergen Drug Corporation, a subsidiary of Cencora, Inc. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC allows for...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract has a ceiling value of $2,233.40 and runs through August 23, 2023. This contract is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds two significant Indefinite Delivery Contracts (IDCs) with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,322.24 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 1.5 mg/0.5 ml Trulicity pens, a medication used to treat type 2 diabetes. The contract has a firm fixed price and is set to expire on May 7, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,388.85 to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the provision of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat type 2 diabetes. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period...
- This federal contract award, valued at $2,898.06, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a type of injectable medication used to treat diabetes. This delivery order has an ultimate completion date of November 9, 2023. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,976.64 contract is for the supply of Trulicity 3 mg/0.5 ml pens, a medication used to treat type 2 diabetes. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract, valued at $6,399.48, has an ultimate completion date of February 23, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through November 2026. This IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Trulicity 1.5 mg/0.5 ml pens. The firm-fixed-price contract is valued at $5,478.17 and has an ultimate completion date of April 11, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,122.59, is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of April 28, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- The Defense Logistics Agency (DLA) awarded a $4,287.66 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a pharmaceutical product used to treat type 2 diabetes. This delivery order is under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR17NDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,322.24 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has a period of performance through November 15, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds two significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000.00 respectively. These IDCs enable the efficient procurement of a wide range of pharmaceutical products and medical supplies to support federal healthcare programs, particularly for the Department of Defense and Department of Veterans Affairs. The contract award does not have a set-aside designation, indicating it was competed on an unrestricted basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/14/23 |